• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
Pharmacokinetics and pharmacogenetics of 13-cis retinoic acid in Indian high-risk neuroblastoma patients 29 September 2016
Circadian rhythmicity and the influence of 'clock' genes on prostate cancer 27 September 2016
Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression 23 September 2016
From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides 22 September 2016
Cancer treatment using peptides: current therapies and future prospects 21 September 2016
Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors 19 September 2016
Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs 19 September 2016
HIGHLY INCREASED 125I-JR11 ANTAGONIST BINDING IN VITRO REVEALS NOVEL INDICATIONS FOR SST2 TARGETING IN HUMAN CANCERS 13 September 2016
Melatonin, an inhibitory agent in breast cancer 13 September 2016
ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion 09 September 2016
Display # 

Page 111 of 172

  • Start
  • Prev
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
  • Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
  • Melatonin in cancer management: progress and promise
  • Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
  • Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study
  • Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
  • The impact of vitamin D on cancer: A mini review
  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Radio-Protective Effects of Melatonin on Subventricular Zone in Irradiated Rat: Decrease in Apoptosis and Upregulation of Nestin
  • Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
  • Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
  • Melatonin: an endogenous miraculous indolamine, fights against cancer progression
  • Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer